Nikos Kokkorakis

The presentation of the Multiparametric Microscopic and Functional Analysis for the Screening of Pharmaceutical Compounds was conducted with interest, as part of the completion of the Scientific Project “DiseasePHENOTarget,” on…

The Long-Awaited Three-Year Study Results on Huntington’s Disease AMT-130, uniQure’s gene therapy, would be the first genetic treatment for Huntington’s disease, if approved. The observed slowing of disease progression is…

CRISPR is being significantly enhanced thanks to DNA-coated nanostructures, which improve the delivery and precision of gene editing, paving the way for safer genetic medicine. Scientists from Northwestern University (USA)…

5th Congress of Cellular And Instrumental Regenerative Medicine Organization: IMSARM, Switzerland When: October 3rd and 4th, 2025 Where: Strasbourg, France HILTON Hotel   In 5th congress in Regenerative Medicine in…

The following review from Gene Therapy of Nature presents the advances and future prospects of gene editing in relation to collagen disorders. Collagen disorders include a broad spectrum of inherited…

A research group funded by the National Institutes of Health (NIH) has successfully created and delivered a personalized gene-editing therapy to treat an infant suffering from a life-threatening, previously untreatable…

After the completion of the electronic voting by the Regular members of the Greek Society of Gene Therapy and Regenerative Medicine (HSGTRM), from June 25 to July 2, 2025, and…

A large research group led by Dr. Jeff Vierstra, a researcher at the Altius Institute for Biomedical Sciences in Seattle (USA), and Dr. Nikoletta Psatha, Assistant Professor in the Department…

This selection of influential and fascinating gene therapy research has been hand-picked by the editors of Cell Stem Cell and Cell Reports Medicine. These are only a few of the…